INOCA and MINOCA are conditions with high risk of cardiac events and frequent persistent ischemic symptoms, and aggressive intervention is needed to reduce risk and symptom burden. This episode will review the data on contemporary treatment of INOCA and MINOCA and discuss additional strategies beyond the data and future directions.

In this interview, Jamieson Bourque, MD., MHS., FACCE and Magnus Ohman MD, FACC, with Michelle D. Kelsey MD, ask if there is evidence for treatment, and discuss data-driven management of in-patients with INOCA and MINOCA.

Related References

1. Contemporary Diagnosis and Management of Patients With Myocardial Infarction in the Absence of Obstructive Coronary Artery Disease: A Scientific Statement From the American Heart Association Jacqueline E. Tamis-Holland, Hani Jneid, Harmony R. Reynolds, Stefan Agewall, Emmanouil S. Brilakis, Todd M. Brown, Amir Lerman, Mary Cushman, Dharam J. Kumbhani, Cynthia Arslanian-Engoren, Ann F. Bolger, John F. Beltrame and On behalf of the American Heart Association Interventional Cardiovascular Care Committee of the Council on Clinical Cardiology; Council on Cardiovascular and Stroke Nursing; Council on Epidemiology and Prevention; and Council on Quality of Care and Outcomes Research See fewer authors Originally published27 Mar 2019https://doi.org/10.1161/CIR.0000000000000670Circulation. 2019;139:e891–e908
2. An EAPCI Expert Consensus Document on Ischemia With Non-Obstructive Coronary Arteries in Collaboration With European Society of Cardiology Working Group on Coronary Pathophysiology & Microcirculation Endorsed by Coronary Vasomotor Disorders International Study Group. Eur Heart J 2020; Jul 6:[Epub ahead of print].
3. What’s in a Name? The Diagnosis, Treatment and Future of INOCA and MINOCA
   
   
   
   Subscribe to the ACCEL Lite Podcast
   
   

   Clinical Topics: Acute Coronary Syndromes, Stable Ischemic Heart Disease

   Keywords: ACCELLite

   
   < Back to Listings